ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

Centers Ask Americans for $1 Each for Research.

May 16, 2008

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Consensus conference On Cervical Cancer

January 26, 1996

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977